Geng Yuechang, Deputy General Manager of Good Doctor Group and Chairman of FNY, attended the meeting and delivered an important speech. He extended sincere gratitude to all participants for their hard work over the past year, and highly recognized the solid progress achieved by FNY in brand building, product R&D and market expansion in 2025. He stressed that facing broad opportunities in the health industry and new challenges brought by industrial transformation, all FNY members shall continue to unite efforts and take a pragmatic approach to jointly usher in a new phase of high-quality and sustainable development.

The meeting announced the list of newly added members of the Strategy Committee and held an appointment ceremony. President Li Nan presented appointment certificates to the new members, marking their official appointment as the backbone of FNY’s business.

At the meeting, President Li Nan delivered a report on the 2026 strategic vision entitled Break Through the Turning Point. He pointed out that 2026 will be FNY’s Breakthrough Year, and the company will carry out systematic arrangements centering on Focus on Value, Achieve Growth Breakthroughs and Pursue Comprehensive Advancement.

He emphasized that taking the Good Doctor Guzheng TCM health management platform as the core, the company will build a service system featuring Intelligent Physical Assessment + Personalized TCM Wellness, offering full-life-cycle health management services for users. To address pain points including difficult customer acquisition and high conversion thresholds, FNY will continuously optimize the Xiaofu Select business, introduce high-frequency daily essential products, lower the threshold for entrepreneurship, and support sustainable market growth.

Vice President You Yan systematically introduced the 2026 product roadmap. She stated that FNY will further advance the integrated innovation of Herbal Medicine + Technology, launching a new product matrix covering multiple lines including beauty peptide series, oral paste portfolio, sports-specific dietary food, weight management products and reproductive health supplies. All products will follow the “Four Questions on Traditional Chinese Medicine” R&D philosophy proposed by Geng Funeng, Chairman of Good Doctor Group, and adopt a full-chain quality control system spanning formula design to empirical verification to guarantee product safety and reliability.

Vice President Zhang Guohua delivered an in-depth analysis on external industrial policies, market compliance management and the construction of orderly market environment. He highlighted that the company will continuously strengthen the dual mechanism of Cultural Guidance & Risk Control, uphold the core value of seeking truth from facts, and strictly adhere to the bottom line of compliant operation. FNY will promote compliance publicity and education, foster a sound ecosystem together with all market participants, firmly oppose all irregular practices, and safeguard the common interests of the brand and business partners.

Vice President Hou Xugang gave a comprehensive overview of the current market landscape, conducted an in-depth analysis of core challenges and clarified directions for improvement. He also elaborated on breakthrough approaches for follow-up market work and corporate empowerment strategies, providing clear operational guidelines for market development.

All participants jointly signed the Beijing Initiative of the Market Strategy Committee of Sichuan FNY Biotechnology Co., Ltd. on Regulating Unauthorized Price-cutting on Online Platforms. The initiative aims to strengthen market self-discipline, jointly resist irregular price competition and false promotion, and advance sound, standardized and orderly market development.

As the closing strategic meeting of FNY in 2025, this session serves as an in-depth review of past achievements and a comprehensive mobilization for the new journey in 2026. Standing at the new starting point of the Breakthrough Year, FNY will continue to uphold its mission Nurture Life with Life, Contribute Chinese Solutions to Global Health. Empowering herbal medicine with technology and defining wellness through digitalization, FNY will stand side by side with all partners to forge ahead and write a new chapter of high-quality and sustainable health business.